Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02196181
Brief Title: Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery

First Submitted : July 18, 2014
First Submitted that Met QC Criteria : July 18, 2014
First Posted : July 21, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 5, 2019
Last Update Posted : September 6, 2019